A detailed history of Nuveen Asset Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 4,677,630 shares of ZTS stock, worth $784 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
4,677,630
Previous 4,752,277 1.57%
Holding current value
$784 Million
Previous $824 Million 10.93%
% of portfolio
0.26%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $12.9 Million - $14.7 Million
-74,647 Reduced 1.57%
4,677,630 $914 Million
Q2 2024

Aug 09, 2024

SELL
$145.54 - $178.83 $35.1 Million - $43.2 Million
-241,434 Reduced 4.83%
4,752,277 $824 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $257 Million - $310 Million
-1,552,223 Reduced 23.71%
4,993,711 $845 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $12.7 Million - $16.7 Million
83,551 Added 1.29%
6,545,934 $1.29 Billion
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $236 Million - $272 Million
1,409,324 Added 27.89%
6,462,383 $1.12 Billion
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $17.7 Million - $20.5 Million
109,892 Added 2.22%
5,053,059 $870 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $14.8 Million - $17.8 Million
-101,697 Reduced 2.02%
4,943,167 $823 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $135 Million - $162 Million
-1,029,045 Reduced 16.94%
5,044,864 $739 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $23.4 Million - $28.8 Million
-157,920 Reduced 2.53%
6,073,909 $901 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $42.9 Million - $55.1 Million
275,362 Added 4.62%
6,231,829 $1.07 Billion
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $38.9 Million - $50.2 Million
-214,308 Reduced 3.47%
5,956,467 $1.16 Billion
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $2.66 Million - $3.39 Million
13,718 Added 0.22%
6,170,775 $1.51 Billion
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $76.1 Million - $84.3 Million
402,205 Added 6.99%
6,157,057 $1.2 Billion
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $23.7 Million - $28.5 Million
151,724 Added 2.71%
5,754,852 $1.07 Billion
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $39.4 Million - $46.3 Million
-273,620 Reduced 4.66%
5,603,128 $882 Million
Q4 2020

May 17, 2021

SELL
$157.07 - $174.35 $5.66 Million - $6.28 Million
-36,047 Reduced 0.61%
5,876,748 $973 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $178 Million - $198 Million
-1,134,013 Reduced 16.09%
5,912,795 $979 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $27.6 Million - $33.3 Million
-201,409 Reduced 2.78%
7,046,808 $1.17 Billion
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $38.2 Million - $48.6 Million
341,152 Added 4.94%
7,248,217 $993 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $79.5 Million - $124 Million
-858,419 Reduced 11.05%
6,907,065 $813 Million
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $23.9 Million - $27.4 Million
205,267 Added 2.72%
7,765,484 $1.03 Billion
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $54.2 Million - $61.8 Million
481,391 Added 6.8%
7,560,217 $942 Million
Q2 2019

Aug 15, 2019

BUY
$97.98 - $114.28 $692 Million - $807 Million
7,061,550 Added 40874.91%
7,078,826 $803 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $306,337 - $368,123
-3,864 Reduced 18.28%
17,276 $1.48 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $33,066 - $36,919
-396 Reduced 1.84%
21,140 $1.94 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $181,293 - $202,394
-2,269 Reduced 9.53%
21,536 $1.84 Million
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $211,526 - $250,513
2,958 Added 14.19%
23,805 $1.99 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $95,871 - $110,364
-1,516 Reduced 6.78%
20,847 $0
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $1.34 Million - $1.46 Million
22,363
22,363 $1.43 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $78.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.